Novo Nordisk, a Danish pharmaceutical corporation, said in a news release that it will invest $4.1 billion to construct a plant in Clayton, North Carolina. This is one of Novo Nordisk's biggest manufacturing investments to date. The new facility will produce injectable medications for obesity and...